KeyScope Study in Uganda

Launched by DUKE UNIVERSITY · Jan 16, 2024

Keywords

ClinConnect Summary

The KeyScope Study in Uganda is a clinical trial that is testing new surgical tools designed to help doctors perform biopsies on tumors in the abdomen. These tools, called KeyScope and KeyLoop, are made specifically for hospitals in low- and middle-income countries. KeyScope is a camera that connects to a laptop to show images during surgery and allows experienced surgeons to guide less experienced ones through a special app. KeyLoop helps hold the abdominal wall open without needing a constant power source, making it easier to operate in settings where resources might be limited.

To participate in this study, patients need to have a suspected cancerous mass in their abdomen and meet certain health criteria, such as having a body mass index (BMI) between 18 and 30 and weighing between 20 and 100 kg. They should also need a biopsy to confirm the diagnosis. However, those with serious health issues, prior major abdominal surgery, or who are currently pregnant cannot take part. If eligible, participants can expect to receive a biopsy using these innovative tools, which could potentially improve surgical outcomes in similar healthcare settings.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • diagnosis of intra-abdominal mass suspicious for cancer
• • body mass index (BMI) of 18-30
• • weight 20-100kg
• • biopsy necessary to determine cancer diagnosis and classify pathology
• • surgeon determine that laproscopic biopsy it technically appropriate
• Exclusion Criteria:
• • significant comorbidities
• • previous major abdominal surgery
• • current pregnancy